Please read and agree to the
terms and conditions
of this site.
I agree
Medical Technology
/tech
Clear filters and search
Format
photo
Tags
boston blog main
boston top stories
boulder/denver blog main
boulder/denver top stories
detroit blog main
detroit top stories
fda
incyte
4
×
indiana blog main
indiana top stories
life sciences
national
national blog main
national top stories
new york blog main
new york top stories
raleigh-durham blog main
raleigh-durham top stories
san diego blog main
san diego top stories
san francisco blog main
san francisco top stories
seattle blog main
seattle top stories
texas blog main
texas top stories
wisconsin blog main
wisconsin top stories
alzheimer's disease
biotech
cancer
clinical trials
eli lilly
europe blog main
europe top stories
glaxosmithkline
startups
baricitinib
biogen
crispr
What
bio
4
×
roundup
crispr
isn’t
new
activity
alliance
approvals
biogen
biopharma
black
bristol
buy
calls
changing
clamped
color
companies
congress
congressional
continue
covid
days
debut
delays
developing
diamond
diamond’s
economic
executives
fast
fda
feud
group
growing
hours
including
indication
ipo
known
Language
unset
Current search:
incyte
×
bio
×
@xconomy.com
3 years ago
Bio Roundup: CRISPR Kudos, Bristol Myers’s Buy, RNAi Alliance & More
@xconomy.com
3 years ago
Bio Roundup: Fast FDA Approvals, Biogen Delays, ORIC’s IPO & More
@xconomy.com
4 years ago
Bio Roundup: Mammoth Moves, Black Diamond’s Pop, Ohana’s Debut & More
@xconomy.com
5 years ago
Bio Roundup: New CRISPR Feud, A NY Splash, Pharma vs. Congress & More